Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
Dispenzieri A, Krishnan A, Arendt B, Blackwell B, Wallace PK, Dasari S, Vogl DT, Efebera Y, Fei M, Geller N, Giralt S, Hahn T, Howard A, Kohlhagen M, Landau H, Hari P, Pasquini MC, Qazilbash MH, McCarthy P, Shah N, Vesole DH, Stadtmauer E, Murray D.
Dispenzieri A, et al. Among authors: wallace pk.
Blood Cancer J. 2022 Feb 10;12(2):27. doi: 10.1038/s41408-022-00624-6.
Blood Cancer J. 2022.
PMID: 35145071
Free PMC article.